Courts / Galway / Report
Pharma giant Teva sues rival over Galway-made product
Summary
Pharmaceutical giant Teva Pharmaceutical Industries Ltd has filed a High Court case against Mylan Teoranta, trading as Mylan International, a Galway‑based subsidiary of the multinational Mylan group. Teva alleges that Mylan has infringed its patents on a 40 mg/ml glatiramer acetate injection used three times a week by patients with relapsing forms of multiple sclerosis. The product is manufactured in Galway and sold on the US market. Mylan denies the infringement claims. Teva seeks several orders, including an injunction to stop Mylan from making, offering or marketing the alleged infringing product, a declaration that such marketing constitutes a trademark infringement, and an order for damages. The case was admitted to the fast‑track commercial court list by Mr Justice Brian McGovern and is scheduled to return before the court in January. The proceedings remain ongoing, with no final judgment yet issued.
Who, what, where, when and why
What: Report matter: Pharma giant Teva sues rival over Galway-made product. Procedural stage: hearing_or_decision
When:
- 2017-11-06 Publication
Places mentioned
- High Court
Topics
Related court reports
- Appearance of tips machine in cafe that pulled in €5k unexplained, tribunal notes
- Judge speaks out about toxic masculinity while jailing young man for rape
- 'You ruined my life,' rape victim tells older brother
- Retired Franciscan brother jailed for 11 years for raping boy
- Lab had to decontaminate first aid room after technician found to have been napping, wearing lead-exposed work gear, tribunal told
- Lithuanian man admits engaging in terrorist plot to attack mosque
If a fact, identity, locality or legal outcome needs review, email the newsroom with this report's details prefilled.
Email a correction request